Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Jul 27, 2022; 14(7): 1333-1343
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1333
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1333
Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings
Zeinab Nabil Ahmed Said, Department of Microbiology & Immunology, Faculty of Medicine for Girls Al-Azhar University, Cairo, Egypt
Manal Hamdy El-Sayed, Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Author contributions: Said ZNA and El-Sayed MH contributed equally to this work.
Conflict-of-interest statement: All the authors declare no conflict of interest in relation to the manuscript.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zeinab Nabil Ahmed Said, PhD, Professor, Department of Microbiology & Immunology, Faculty of Medicine for girls Al-Azhar University, Nasr City, Cairo 11754, Egypt. znabil58@yahoo.com
Received: October 7, 2021
Peer-review started: October 7, 2021
First decision: December 2, 2021
Revised: January 30, 2022
Accepted: June 13, 2022
Article in press: June 13, 2022
Published online: July 27, 2022
Peer-review started: October 7, 2021
First decision: December 2, 2021
Revised: January 30, 2022
Accepted: June 13, 2022
Article in press: June 13, 2022
Published online: July 27, 2022
Core Tip
Core Tip: This minireview presents the data and challenges associated with hepatitis B virus (HBV) and hepatitis C virus (HCV)/coinfection in resource-limited settings. It also underlines the key gaps and strategies for elimination of HBV and HCV infections in the low and middle-income countries. Global efforts should continue to improve awareness and political commitment. Equally important is securing financial resources for access and implementation of comprehensive strategies for diagnosis and linkage to care in resource-constrained settings to fulfill the 2030 elimination goal.